Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. - Wikidata - wikimedia - TriplyDB

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

http://www.wikidata.org/entity/Q34193507

about

Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy Haploidentical Transplantation in Children with Acute Leukemia: The Unresolved Issues The role of NK cells in HIV-1 protection: autologous, allogeneic or both?Selection and expansion of natural killer cells for NK cell-based immunotherapy Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy Enhancing Cancer Immunotherapy Via Activation of Innate Immunity NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect Natural killer cell biology: an update and future directions Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphoma Outcomes from unrelated donor hematopoietic stem cell transplantation Targeted immunotherapy for acute myeloid leukemia Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments Manufacturing Natural Killer Cells as Medicinal Products Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?Improving natural killer cell cancer immunotherapy NK cells in therapy of cancer HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors Impaired NK-cell education diminishes resistance to murine CMV infection Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies.Presence of the full-length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment.Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease KIR B or not to be?...that is the question for ALL.KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL.Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals Recombinant structures expand and contract inter and intragenic diversification at the KIR locus NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease.Natural killer cell-based therapies.Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation

P2860

Q26744654-6B7F919D-C016-4ACB-AD46-7309B3F1C11B Q26750671-61EFCB61-93C6-4541-B0A0-3DC1C4AA2265 Q26753146-CFF733DE-C36D-4F9A-AF3F-9C2C6BCE726E Q26774777-A2249E74-D1CC-45CB-88EC-244A43F6A199 Q26777209-B2163A06-B3B1-444C-A251-87EC07113ABE Q26796313-10A0BD0F-9677-4C6C-85F7-D458DF18D012 Q26797345-54EF9B54-89B0-4DCA-A255-A60574C13E92 Q26826830-F3AC254D-ACEA-4BC8-B88C-150939F5CC1B Q26830512-9A5C9D60-D7C3-46E2-80D3-499D578BD5C1 Q26996660-77D0A362-DC36-4C65-A25F-938188D6F0EC Q26999011-FBD39D01-AB89-4207-9B60-0F4377D49D38 Q27027854-3238EBFD-F636-4C8F-9D84-E65239120165 Q27687636-8D2D8F2F-7E64-4C0E-80F9-59164432B094 Q28067102-025D5C23-14C0-49BF-8206-8F2E0098BB2A Q28069992-6786BA51-0F95-476C-AC2F-348A7137BE22 Q28080914-A736B2B3-CD26-4C39-9B2A-E966E7AD8662 Q28087719-A9FAA3CC-D6DA-4092-93FC-5F568C64295A Q28242241-5937C089-3F7B-412D-B47A-D87423B78B52 Q28298119-EDDE8053-4F39-42E1-A299-4B132AE5782F Q30370102-5CEDBCC4-7753-4EE0-9AC7-A5D6DADBCE4C Q33651178-2E0DBC3C-138A-4A59-A70B-31448D82E66D Q33703046-FFCD85C0-C175-4200-948B-9521662CDCA7 Q33734571-90308C8D-F782-4AB4-90D9-59CAECB6DFC7 Q33856960-3A84541A-232C-4DB2-94E1-C53BF4131CE7 Q33987886-43BD0271-2F0B-42AA-B725-34DDA8CFE774 Q34175568-7E7B039D-CCC4-4ABC-962A-733A56E99A5E Q34192841-2E537E87-CD41-4699-A0DF-98C265BA26DF Q34245469-90A76DC2-61C4-4FEF-AC36-CD9B1B84D0A8 Q34307792-8680F33F-32A4-41D9-9A47-3CC1CD4C5288 Q34398333-E3A04DB3-28DC-482A-8E87-BACF5DF6EB0B Q34398420-04FFAF3C-A0C9-4E6D-8141-C25A9F4DAA1A Q34471812-11B0C19D-4D19-4A0A-A4AE-63CCFC1DE043 Q34581495-68C087EC-D156-489A-84EF-E1E4EFFFE5DB Q34615804-D345C439-62D6-435C-AB5B-B03F1B04559E Q34988727-DBA2CFBC-CDC9-4113-A191-562BAD3C4963 Q35029441-8EDDF617-F007-404A-8776-6C15F1B0E3E1 Q35070933-1CA7E29B-A344-4BE8-BF57-A4406BAEE450 Q35071326-C19B45D1-87C4-436D-980C-8719B5D78050 Q35212365-E87438F3-BA9E-477E-B1E5-405A67EFC513 Q35242680-784BBC6C-BD11-4437-9CC9-F56D3E0F32F3

P2860

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

http://www.wikidata.org/entity/Q34193507

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Donor selection for natural ki ...... or acute myelogenous leukemia.

@ast

Donor selection for natural ki ...... or acute myelogenous leukemia.

@en

Donor selection for natural ki ...... or acute myelogenous leukemia.

@nl

type

label

Donor selection for natural ki ...... or acute myelogenous leukemia.

@ast

Donor selection for natural ki ...... or acute myelogenous leukemia.

@en

Donor selection for natural ki ...... or acute myelogenous leukemia.

@nl

prefLabel

Donor selection for natural ki ...... or acute myelogenous leukemia.

@ast

Donor selection for natural ki ...... or acute myelogenous leukemia.

@en

Donor selection for natural ki ...... or acute myelogenous leukemia.

@nl

P1433

Q34193507-C1C92F72-060A-439E-91AB-3E4A47952E8B

P1476

Q34193507-EE056200-E649-4B1E-B127-D09A1C1EE5A4

P2093

Q34193507-00D94FCB-AEEB-46D7-8C41-E9BE2A225C50

Q34193507-05EF07CB-BA15-4C78-A01E-9BD0D08FC713

Q34193507-3029CDD3-1273-40C8-8BBF-110FC0B629EA

Q34193507-7EEAB80E-72E2-4732-A02F-8AECCF2A0133

Q34193507-8C715FBE-AEC4-4018-A4E2-B0E3270DE202

Q34193507-8FB53F06-173F-44FC-A967-F5EA17B01959

Q34193507-94741098-E65E-44C8-82FC-256133839EFB

Q34193507-9707A638-0D67-481D-B3D2-F30C49AF762B

Q34193507-A0450CF8-BCA6-4EAB-9DC4-7143B7197BB1

Q34193507-CE7E11F6-3B1D-4B1A-A775-508F73CCB58F

P2860

Q34193507-006CD7AF-33F2-4BD0-8D97-7406ACE5E4C0

Q34193507-06A93B3C-E312-40ED-9A65-5DC4CEC9228C

Q34193507-08874741-6B98-491E-B2DB-D83D86A4E516

Q34193507-090CB361-D0A8-4464-B196-013A1CAF5764

Q34193507-0AF41C68-9FAF-4417-933D-FCBAB77D30A6

Q34193507-130164A5-EC4D-4E46-A1F0-090B3EF5AF8B

Q34193507-134A0197-AC8F-4166-A7B1-C8A0A9883BCA

Q34193507-169A1E86-6D54-4DD5-843C-F7162E0E2366

Q34193507-2EC92E8A-67CF-41DF-A3F3-9CCB8CCDB63E

Q34193507-37367F72-9C16-419B-A920-55678B86E836

P304

Q34193507-0C3EC2F7-D96C-4450-A8E3-E2DDC91941A6

P31

Q34193507-4A100481-475B-4BFE-97C1-989CC8D025B2

P356

Q34193507-EE8407E7-8823-43A1-BC5F-744419A6D28F

P407

Q34193507-61F6D11A-6319-4209-935A-689F87AF953B

P433

Q34193507-F76C5709-C7F3-4A0B-8D1A-C85BD93FED04

P478

Q34193507-CED5BBCC-E6FC-4C77-84D5-9A960C0842F4

P50

Q34193507-7C05548C-28FF-43A3-BF4D-EF587030273E

P577

Q34193507-297E5A0A-C868-45AB-92DB-4740DC0FF986

P5875

Q34193507-CD05E6CB-9C95-424B-9914-25BEFF72E995

P698

Q34193507-A7363B3F-21A0-41C9-BAF6-E1B89C2AF147

P921

Q34193507-1C26353A-16F6-485F-955F-C470BA608AC0

P932

Q34193507-54D8970A-904F-4E6E-9A94-43BA74113028

P356

BLOOD-2010-05-283051

P1433

P1476

Donor selection for natural ki ...... or acute myelogenous leukemia.

@en

P2093

Chap T Le

http://www.w3.org/2001/XMLSchema#string

Daniel Geraghty

http://www.w3.org/2001/XMLSchema#string

Daniel J Weisdorf

http://www.w3.org/2001/XMLSchema#string

Elizabeth Trachtenberg

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Miller

http://www.w3.org/2001/XMLSchema#string

John P Klein

http://www.w3.org/2001/XMLSchema#string

Lisbeth A Guethlein

http://www.w3.org/2001/XMLSchema#string

Martha Ladner

http://www.w3.org/2001/XMLSchema#string

Michael D Haagenson

http://www.w3.org/2001/XMLSchema#string

Peter Parham

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

Plasticity in the organization and sequences of human KIR/ILT gene families

Conservation and variation in human and common chimpanzee CD94 and NKG2 genes

In search of the 'missing self': MHC molecules and NK cell recognition

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors

Human diversity in killer cell inhibitory receptor genes

Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles.

P304

2411-2419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2010-05-283051

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Steven G. E. Marsh

P577

2010-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44803226

http://www.w3.org/2001/XMLSchema#string

P698

20581313

http://www.w3.org/2001/XMLSchema#string

P921

P932

2953880

http://www.w3.org/2001/XMLSchema#string